SCM
MDCO

Sterling Capital Management’s Medicines Co MDCO Stock Holding History

Sterling Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8.69M Buy
173,706
+27,620
+19% +$1.1M 0.08% 189
2019
Q2 		$5.33M Sell
146,086
-10,114
-6% -$330K 0.05% 247
2019
Q1 		$4.37M Buy
156,200
+15,950
+11% +$376K 0.04% 261
2018
Q4 		$2.68M Buy
+140,250
New +$3.26M 0.03% 320

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Sterling Capital Management's MDCO Position: Q3 2019 in Review

Sterling Capital Management increased its Medicines Co (MDCO) stake by 19% in Q3 2019, buying an estimated $1.1M and bringing the position to 173,706 shares worth $8.69M. The position accounts for 0.08% of the portfolio, ranked #189.

Sterling Capital Management first reported a position in MDCO in Q4 2018 and has held it in 4 quarters since. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • Sterling Capital Management held 173,706 shares of Medicines Co worth $8.69M as of Q3 2019.
  • Sterling Capital Management bought 27,620 Medicines Co shares in Q3 2019, an estimated $1.1M.
  • Medicines Co made up 0.08% of Sterling Capital Management's portfolio in Q3 2019, its #189 holding.
  • Sterling Capital Management first reported a position in Medicines Co in Q4 2018 and has held it in 4 quarters since.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Sterling Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.